PubMed:27184800 / 129-294
Annnotations
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 0-165 | Sentence | denotes | Sorafenib, a kinase inhibitor active against various solid tumours, induces oxidative stress and ferroptosis, a new form of oxidative necrosis, in some cancer cells. |
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 11327 | 0-9 | ChemicalEntity | denotes | Sorafenib | MESH:D000077157 |
| 11328 | 59-66 | DiseaseOrPhenotypicFeature | denotes | tumours | MESH:D009369 |
| 11329 | 134-142 | DiseaseOrPhenotypicFeature | denotes | necrosis | MESH:D009336 |
| 11330 | 152-158 | DiseaseOrPhenotypicFeature | denotes | cancer | MESH:D009369 |
LitCoin_Mondo
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T3 | 152-158 | DiseaseOrPhenotypicFeature | denotes | cancer | 0004992 |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 13-29 | GeneOrGeneProduct | denotes | kinase inhibitor |
| T4 | 30-36 | GeneOrGeneProduct | denotes | active |
| T5 | 68-75 | GeneOrGeneProduct | denotes | induces |
| T6 | 159-164 | GeneOrGeneProduct | denotes | cells |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 13-29 | GeneOrGeneProduct | denotes | kinase inhibitor |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T2 | 59-66 | DiseaseOrPhenotypicFeature | denotes | tumours | DISEASE |
| T3 | 134-142 | DiseaseOrPhenotypicFeature | denotes | necrosis | D009336 |
| T4 | 152-158 | DiseaseOrPhenotypicFeature | denotes | cancer | D009369 |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 13-29 | GeneOrGeneProduct | denotes | kinase inhibitor |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T2 | 59-66 | DiseaseOrPhenotypicFeature | denotes | tumours | DISEASE |
| T3 | 134-142 | DiseaseOrPhenotypicFeature | denotes | necrosis | D009336 |
| T4 | 152-158 | DiseaseOrPhenotypicFeature | denotes | cancer | D009369 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T2 | 59-66 | DiseaseOrPhenotypicFeature | denotes | tumours | DISEASE |
| T3 | 152-158 | DiseaseOrPhenotypicFeature | denotes | cancer | D009369 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T4 | 0-9 | ChemicalEntity | denotes | Sorafenib | D000077157|http://purl.obolibrary.org/obo/CHEBI_50924 |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T4 | 0-9 | ChemicalEntity | denotes | Sorafenib | http://purl.obolibrary.org/obo/CHEBI_50924|D000077157 | |
| T54816 | 13-29 | GeneOrGeneProduct | denotes | kinase inhibitor | ||
| T39241 | 152-158 | DiseaseOrPhenotypicFeature | denotes | cancer | D009369 | |
| T22881 | 59-66 | DiseaseOrPhenotypicFeature | denotes | tumours | DISEASE |